Op-ed urges policymakers to protect compounding's original purpose
The commentary argues compounding should remain a patient-specific practice rather than a channel that strains the medicine supply chain.
DO
By Daniel Okafor · Regulatory Correspondent
Oct 6 08:57 ETSource: The Well News
The wire
- 01The Well News published commentary calling on policymakers to act to preserve the intended purpose of drug compounding and the integrity of the medicine supply chain.
- 02Compounders, 503A and 503B operators and telehealth prescribers are the direct subjects of this policy debate, which shapes what can legally be compounded and sold.
- 03It is an opinion piece rather than a regulatory action, and no agency has proposed the changes it calls for.
From the source
Read at thewellnews.comPolicymakers Must Take Action to Preserve the Purpose of Medication Compounding and the Integrity of the Medicine Supply Chain
